International Group Brings Inequities Of Health Research To World's Attention

At first glance the mandate set before the Commission on Health Research for Development when it was formed in 1987 may have read like an assignment from Mission Impossible: "to survey current health research worldwide, identify strengths and weaknesses, and propose improvements." But the independent international commission, headquartered in Cambridge, Mass., completed its task (the first of its kind) and recently published its findings in a 136-page report entitled "Health Research: Essential

Written byAngela Martello
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

At first glance the mandate set before the Commission on Health Research for Development when it was formed in 1987 may have read like an assignment from Mission Impossible: "to survey current health research worldwide, identify strengths and weaknesses, and propose improvements." But the independent international commission, headquartered in Cambridge, Mass., completed its task (the first of its kind) and recently published its findings in a 136-page report entitled "Health Research: Essential Link To Equity In Development." The report contains the results of a two-year survey that focused on health research activities, research capacity, and research support in 10 developing countries.

In essence, what the commission found is that the life span of those living in developing countries is one third shorter than that of people living in industrialized countries. Shorter life spans coupled with other health issues hinder economic, political, and social development. The commission also found a gross ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies